Skip to main content Skip to main navigation menu Skip to site footer
Journal of Commercial Biotechnology
  1. Home /
  2. Archives /
  3. Vol. 20 No. 3 (2014)

Vol. 20 No. 3 (2014)

Published: 2014-07-01

Commentary

  • Who Lost Opioids?

    Peter J. Pitts
    • PDF
  • GM tea: the need of the hour to reclaim India’s leading position in the global tea market

    Debajit Borah, Amrita Kashyap Chaliha, Dhrubajyoti Gogoi, RNS Yadav
    • PDF

Article

  • What makes a happy team? Data from 5 years’ entrepreneurship teaching suggests that working style is a major determinant of team contentment.

    William Bains
    • PDF
  • Ethical, Legal, and Regulatory Issues Regarding the Study and Use of Medications in Pregnant Women

    Diana Pham
    • PDF

From the Classroom

  • The University of Colorado Digital Health Consortium Initiative: A Collaborative Model of Education, Research and Service

    Jiban Khuntia, Jahangir Karimi, Mohan Tanniru, Arlen Meyers
    • PDF

Legal and Regulatory Updates

  • Staking an Advantage in an AIA World: Practical Patent Tips for Biotechnology Companies

    Stefan Michael Miller
    • PDF
  • USPTO Guidance On Patentable Subject Matter: Impediment to Biotech Innovation?

    Joanna T. Brougher, David A. Fazzolare
    • PDF
  • EU Legal & Regulatory Update – June 2014

    Ewan Grist
    • PDF

Conference Report

  • Four Perspectives on Business Model Evolution in Synthetic Biology

    Karl Schmieder, Clara Andrew-Wani
    • PDF

Book Review

  • India's Healthcare Industry: Innovation in Delivery, Financing, and Manufacturing

    Susan Finston
    • PDF

Copyright © 2021
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

Journal of Commercial Biotechnology

GoDaddy SiteSeal WebTrust